All webinar times are in Eastern Time except where noted. Convert to your time zone.
Acute kidney injury (AKI) is recognized globally as a major determinant of chronic kidney disease and cardiovascular mortality. It is associated with doubled length of hospital stay, increased costs of care and a significant increase in in-hospital mortality. Unfortunately, underrecognition and underdiagnosis of AKI remain a leading concern worldwide. With approximately 1 out of every 10 inpatients developing AKI, opportunities for early identification and treatment of AKI are significant. Recognizing that early detection of AKI through laboratory-initiated alerts can lead to more effective treatments, reduced long- and short-term complications and reduced costs.
An integrated clinical care team from Ernst-von-Bergmann Hospital Potsdam and the University Hospital in Magedeburg, sought to improve recognition and treatment of in-hospital AKI. This webinar presents their novel best practice in which they implemented a hospital-wide electronic AKI alert based on serum creatinine [KDIGO-AKI practice guidelines], with accompanying nephrologist-optimized treatment recommendations and patient education. This collaboration led to an increase in detection and documentation of AKI, increased patient awareness and reduced disease burden.
What you will learn -
- The current gaps in and opportunities for identifying and treating AKI in in-hospital patients
- To appreciate how a combination of hospital-wide electronic alerts, nephrologist-derived treatment plans, and patient education can optimize AKI identification, treatment, and patient care
- The impact of working in a multidisciplinary team to increase quality of care for patients, improve patient safety, increase clinician confidence, and reduce AKI related complications
Michael Haase, MD
Nephrologist, Researcher, Associate Professor of Medicine
Otto-von-Guericke University of Magdeburg